JAMIE BUSCH: Open Payments
NPI 1306312848 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$35,317 in 50 payments from 13 companies in 2025. Trend: 2023 $1,367 · 2024 $23,460 · 2025 $35,317
Speaker / faculty: $27,564Consulting: $5,438Food & beverage: $1,255Travel & lodging: $1,060
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 31 | $34,743 |
| SK Life Science, Inc. | 1 | $116 |
| ACADIA Pharmaceuticals Inc | 1 | $115 |
| ABBVIE INC. | 3 | $58 |
| Abbott Laboratories | 3 | $54 |
| UCB, Inc. | 2 | $40 |
| Axsome Therapeutics, Inc. | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| CSL Behring | 1 | $28 |
| Genentech USA, Inc. | 1 | $28 |
Products named: INGREZZA, XCOPRI, NUPLAZID, INFINITY, Symbravo, NURTEC ODT, BOTOX, Hizentra.
Industry payments across SD — which companies pay providers there.
